arrow_back Back Filing freshness 10-Q FY 2022 SEC EDGAR

Bioquest Corp

BQST
Price unavailable
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
5 Visible periods
16 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Bullish
auto_awesome

Analytical Summary

Bioquest Corp shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC 149.2%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

5-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-821.02K
↑ +64.7%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
100
Financial Health
22
Cash Quality
24

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 22 quarters